Diabetic retinopathy (DR) screening is a strong use case for applied AI in India: the patient pool is large, ophthalmologists are concentrated in cities, and screening can be shifted closer to primary care. But the purchase price of an automated diabetic retinopathy detection system is only one part of the decision. A reliable programme also needs a suitable fundus camera, trained operators, referral pathways, connectivity, quality controls and a plan for maintenance.
This guide provides realistic planning ranges for 2026. Treat them as procurement estimates, not vendor quotations. Final pricing depends on camera type, screening volume, AI claims, clinical validation, integration requirements and whether the system is deployed in a hospital, diagnostic chain, NGO programme or public-health network.
Estimated cost at a glance
A small Indian screening site may require ₹3 lakh–₹8 lakh in first-year spending when using a portable camera, cloud software and limited integration. A larger hospital or multi-site programme can spend ₹10 lakh–₹35 lakh or more, particularly when it uses premium cameras, on-premise inference, PACS/HIS integration, clinical validation and formal support contracts.
Typical planning ranges include:
- Portable fundus camera: ₹2 lakh–₹6 lakh
- Desktop fundus camera: ₹5 lakh–₹15 lakh or more
- Edge computer and accessories: ₹50,000–₹2.5 lakh
- AI screening licence: ₹100–₹800 per screened patient, or roughly ₹5 lakh–₹25 lakh annually for enterprise plans
- Integration and implementation: ₹1 lakh–₹10 lakh
- Training and workflow setup: ₹25,000–₹2 lakh per site
- Annual support, calibration and maintenance: commonly 8%–20% of hardware value, excluding major repairs
These ranges should be converted into a three-year total cost of ownership before comparing suppliers.
What the system includes
Camera and image-capture hardware
The camera determines image quality, portability, operator learning time and the types of patients who can be screened successfully. Portable cameras are usually better for camps, mobile vans and rural health centres. Desktop cameras offer a more controlled setup and may produce fewer ungradable images, but they need a dedicated room and stable power.
Budget separately for a laptop or tablet, backup power, network equipment, patient-positioning accessories, printer requirements and secure storage. A camera that appears inexpensive can become costly if it requires proprietary consumables, paid service visits or a dedicated workstation.
AI software
Vendors commonly price AI in one of four ways:
- Per-image or per-patient: useful for pilots and variable volumes, but expensive at scale.
- Monthly subscription: easier to budget for a single site.
- Annual site licence: suitable for hospitals with predictable throughput.
- Enterprise or network licence: negotiated for multiple facilities, APIs and central reporting.
Ask whether the quoted price includes repeat uploads, both eyes, unreadable-image handling, clinician review, dashboard access, software updates and data export. A “screened patient” may mean one patient, one eye or one image; the contract should define this clearly.
Integration and reporting
A standalone web portal may be enough for a pilot. A hospital network may need integration with registration, billing, EMR, PACS, laboratory systems or a state health dashboard. API work, identity management, audit logs and result reconciliation can add ₹1 lakh–₹10 lakh depending on the legacy environment.
If the project includes several automated workflows, document the architecture early. Lessons from building distributed systems with AI agents are relevant here: define service boundaries, failure handling, observability and human escalation instead of treating the AI model as the whole system.
Cloud, edge or hybrid deployment
Cloud inference minimises upfront infrastructure and makes central model updates easier. It works well when sites have dependable connectivity and when the vendor provides suitable Indian data-hosting and security controls. Recurring storage, bandwidth and API charges must be included in the operating budget.
Edge inference processes images at the facility. It reduces dependence on connectivity and may suit outreach programmes, but adds hardware, local support and update responsibilities. It also requires a process for synchronising results when the connection returns.
A hybrid design is often practical: run the first result locally, synchronise encrypted images and metadata later, and permit remote review for ungradable or referable cases. Compare each model using cost per completed, gradable screening—not simply cost per upload.
Clinical quality and regulatory diligence
The cheapest model is not necessarily the lowest-cost system if it creates excessive false positives, misses referable disease or produces too many ungradable images. Request evidence for performance on Indian populations and on the exact camera models proposed. Review sensitivity, specificity, gradability, disease thresholds, subgroup performance and the confidence or uncertainty policy.
Clarify the product’s intended use and regulatory position in India. Ask the supplier to explain applicable CDSCO requirements, quality-management certifications, clinical evidence, cybersecurity controls and responsibility for post-market monitoring. A model cleared for one screening claim should not automatically be marketed as a diagnostic tool for every stage of DR.
The workflow must also state what happens after an abnormal result. AI should support screening and triage; it does not replace a qualified ophthalmologist’s examination, treatment decision or follow-up plan. Include referral transport, appointment booking, patient communication and missed-follow-up tracking in the programme budget.
Staffing and operating costs
A technician or community health worker still needs training in patient consent, dilation policy, camera positioning, image capture, infection control and repeat imaging. Plan for a supervisor who reviews quality metrics and handles exceptions. Staffing costs may exceed the AI licence at low volumes.
Track these measures monthly:
- Screening completion rate and average time per patient
- Percentage of images marked ungradable
- AI-to-specialist agreement on sampled cases
- Referral completion and treatment initiation
- Cost per gradable patient and cost per confirmed referable case
- Downtime, turnaround time and support-ticket resolution
For patient-facing reminders or referral coordination, teams may also evaluate conversational AI vs voice agents, but any automation must protect consent, language accessibility and clinical escalation.
Building an India-specific business case
Start with volume. At 500 patients per month, a per-screen fee may be safer than a large annual commitment. At 5,000 or more monthly screenings, negotiate an enterprise rate and calculate whether local inference lowers connectivity and usage costs. Include the cost of repeat images, failed uploads, technician time and specialist over-reads.
A simple model is:
Three-year cost per completed screening = (hardware + implementation + three years of software, support, connectivity and staffing) ÷ completed gradable screenings.
Then compare that figure with the cost of specialist-only screening, travel to referral centres and preventable late-stage treatment. Do not claim ROI solely from additional procedures; public programmes should prioritise earlier detection, treatment access and reduced avoidable vision loss.
Procurement checklist
Before signing, ask vendors for:
- A live demonstration using your camera, connectivity and representative images
- Definition of billable units and all licence limits
- Evidence of performance and validation by camera and patient population
- Data ownership, retention, deletion, export and breach-notification terms
- Integration specifications, uptime commitments and support hours
- Hardware warranty, calibration schedule and replacement timelines
- Model-update policy, audit trails and change-control documentation
- A 60–90-day pilot with agreed success metrics and exit terms
For founders developing affordable screening tools, grants and pilot partnerships can reduce the burden of clinical validation and deployment. AI Grants India supports Indian AI ventures working on high-impact applications, including healthcare infrastructure and diagnostics.
Bottom line
For a single Indian site, budget ₹3 lakh–₹8 lakh for a practical first year and validate the workflow before expanding. For a hospital network, plan for ₹10 lakh–₹35 lakh or more, with integration, governance and support treated as core costs rather than extras. The right purchase is the system that delivers reliable, gradable images, clinically appropriate referrals and measurable cost per completed screening—not simply the lowest AI licence.